Determinants of interleukin-12 in stable ischaemic heart disease
Cardiovascular Endocrinology · 2014
DOI: 10.1097/xce.0000000000000031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Endocrinology, 2014. Verfasst von Iiris Salonen und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Objective
The aim of this study was to determine the relation of plasma interleukin-12 (IL-12) concentration to major risk factors of atherosclerosis and other personal characteristics in well-documented, stable ischaemic heart disease (IHD) patients. The hypothesis was that IL-12 is positively associated with inflammatory markers and risk factors of atherosclerosis. Materials and methods Clinical data were collected from 51 IHD patients by a questionnaire and from basic laboratory blood tests. The association of IL-12 with the biochemical, personal, health status and lifestyle determinants was investigated by regression analysis and analysis of variance.
Results
Plasma IL-12 concentration was associated inversely with the plasma concentration of triglycerides (P=0.001) and homocysteine (P=0.04). However, IL-12 was associated directly with the concentration of high-density lipoprotein cholesterol (P=0.03). IL-12 concentration was not strongly associated with other biochemical parameters nor with the health status, medication or lifestyle determinants.
Conclusion
The results suggest that, contrary to the hypothesis, IL-12 was associated inversely with plasma levels of two known risk factors of coronary atherosclerosis (triglycerides, homocysteine) in stable, statin-medicated IHD patients. The lack of association of IL-12 with high-sensitivity C-reactive protein, erythrocyte sedimentation rate and the number of inflammatory cells in blood suggests that moderately elevated IL-12 did not imply ongoing systemic inflammation in these patients. Although increased IL-12 production is a sign of proinflammatory activity, it was associated directly with the plasma high-density lipoprotein cholesterol concentration. Overall, moderately elevated plasma IL-12 concentration may even be a good sign in stable IHD patients.
Zitieren
APA
Salonen, I., Huttunen, K., Hirvonen, M., Dufva, J., Groundstroem, K., Dufva, H., & Salonen, R. O. (2014). Determinants of interleukin-12 in stable ischaemic heart disease. Cardiovascular Endocrinology. https://doi.org/10.1097/xce.0000000000000031
Vancouver
Salonen I, Huttunen K, Hirvonen M, Dufva J, Groundstroem K, Dufva H, et al. Determinants of interleukin-12 in stable ischaemic heart disease. Cardiovascular Endocrinology. 2014. doi:10.1097/xce.0000000000000031
BibTeX
@article{Salonen2014,
author = {Salonen, Iiris and Huttunen, Kati and Hirvonen, Maija-Riitta and Dufva, Juhani and Groundstroem, Kaj and Dufva, Hilkka and Salonen, Raimo O.},
title = {Determinants of interleukin-12 in stable ischaemic heart disease},
journal = {Cardiovascular Endocrinology},
year = {2014},
doi = {10.1097/xce.0000000000000031}
}
EUVIMED